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Dear colleagues,
This issue of the European Archives of Psychiatry and
Clinical Neurosciences is mainly dealing with topics
around affective disorders.
A large-scale 15 year-follow-up of 323 ﬁrst hospitalized
patients documents the substantial differences in outcome
between schizophrenia and affective disorders [1]. This
difference was most pronounced in the Strauss-Carpenter-
Scale, male sex and several psychopathological syndromes.
During a large-scale follow-up of 320 patients with bipolar
disorder [2] duration of untreated illness (DUI) was cor-
related with worse outcome, mainly increased suicidality
and suicide attempts. In this respect, another interesting
paper [3] supports the association of seasonality of suicide
attempts and gender. Interestingly female gender is asso-
ciated with a reduction of suicide attempts in spring by
10%.
In a large-scale four-level community-based interven-
tion program conducted in Nu ¨rnberg (Nu ¨rnberg alliance
against depression (NAD)), it was shown that the number
of suicide acts (main outcome completed and attempted
suicide) dropped signiﬁcantly (-21.7%) comparing the
baseline year and the control region. Interestingly
sustainable effects on suicidality could be maintained one
year after the main intervention [4].
One of the hot topics of treatment prediction is phar-
macogenetics. In a review article on the pharmacogenetics
of antidepression treatment evaluating the current literature
[5], it was found that there is currently a focus on new
candidate single nucleotide polymorphisms—particularly
in the 5HT2A-receptor gene and the gene coding for the
cochaperone FKBP5. However, the article concluded that
the ‘‘pharamacogenetics of therapeutic effects and off side
effects of antidepressants are unable to guide decisions on
the selection of the most beneﬁcial drug for an individual
patient’’.
Finally two articles on interesting innovative neurobio-
logical aspects of psychiatric disorders should be men-
tioned. The article by Koch et al. [6] found increased
fractional anisotrophy (FA) in cortico pontine-cerebellar
circuits in schizophrenia compared to control subjects
suggesting some neuroplastic changes in these networks.
This ﬁnding is in contrast to a solid literature suggesting
reduced fractional anisotrophy in extended cortical and
subcortical white matter fractions in schizophrenia. The
second article points in a similar direction [7] combining
ERP and fMRI in subjects with ADHD compared to con-
trols using a go/no go-task. Reduced medial/lateral frontal
activity was demonstrated supporting the involvement of
this neural network in different psychiatric disorders
including ADHD.
We hope you will enjoy reading the articles of the
August issue during this hot summer.
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